Francisella tularensis alters human neutrophil gene expression: Insights into the molecular basis of delayed neutrophil apoptosis

Journal of Innate Immunity

Volumn 5, Issue 2, 2013, Pages 124-136

  Schwartz, Justin T ^a,b   Bandyopadhyay, Sarmistha ^a,c   Kobayashi, Scott D ^d   McCracken, Jenna ^a,b   Whitney, Adeline R ^d   Deleo, Frank R ^d   Allen, Lee Ann H ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Apoptosis; BAX; Gene expression; Microarray; Neutrophil; Polymorphonuclear leukocyte; Tularemia; XIAP

Indexed keywords

BACTERIAL VACCINE; BCL2 RELATED PROTEIN A1; CASPASE 2; CASPASE 8; CXCL1 CHEMOKINE; CYCLIN DEPENDENT KINASE 2; FLICE INHIBITORY PROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LIVE VACCINE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; PROTEIN; PROTEIN BAX; PROTEIN BCL 3; PROTEIN BIRC3; PROTEIN GADD45B; PROTEIN NFKB1; PROTEIN NFKB2; PROTEIN PBEF1; PROTEIN PIM2; PROTEIN TNFAIP3; PROTEIN TNFRSF10D; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR 3; UNCLASSIFIED DRUG; VASCULOTROPIN; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; FRANCISELLA TULARENSIS; GENE EXPRESSION; GENETIC ASSOCIATION; GLOBAL CHANGE; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NEUTROPHIL; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; UPREGULATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; CELL SURVIVAL; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; FRANCISELLA TULARENSIS; GENE EXPRESSION REGULATION; HUMANS; MICROARRAY ANALYSIS; NEUTROPHILS; NF-KAPPA B; SIGNAL TRANSDUCTION; TULAREMIA; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84876126888     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000342430     Document Type: Article

References (42)

1. Kennedy A, DeLeo F: Neutrophil apoptosis and the resolution of infection. Immunol Res 2009; 43: 25-61.
2. Geering B, Simon HU: Peculiarities of cell death mechanisms in neutrophils. Cell Death Differ 2011; 18: 1457-1469.
3. Kobayashi SD, Voyich JM, Braughton KR, DeLeo FR: Down-regulation of proinflammatory capacity during apoptosis in human polymorphonuclear leukocytes. J Immunol 2003; 170: 3357-3368.
4. Kobayashi SD, Voyich JM, Somerville GA, Braughton KR, Malech HL, Musser JM, De-Leo FR: An apoptosis-differentiation program in human polymorphonuclear leukocytes facilitates resolution of inflammation. J Leukoc Biol 2003; 73: 315-322.
5. Kobayashi SD, DeLeo FR: Role of neutrophils in innate immunity: a systems biologylevel approach. Wiley Interdiscip Rev Syst Biol Med 2009; 1: 309-333.
6. Jack RM, Fearon DT: Selective synthesis of mRNA and proteins by human peripheral blood neutrophils. J Immunol 1988; 140: 4286-4293.
7. Kobayashi SD, Braughton KR, Whitney AR, Voyich JM, Schwan TG, Musser JM, DeLeo FR: Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci USA 2003; 100: 10948-10953.
8. Kobayashi SD, Voyich JM, Buhl CL, Stahl RM, DeLeo FR: Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: cell fate is regulated at the level of gene expression. Proc Natl Acad Sci USA 2002; 99: 6901-6906.
9. Watson RW, Redmond HP, Wang JH, Condron C, Bouchier-Hayes D: Neutrophils undergo apoptosis following ingestion of Escherichia coli . J Immunol 1996; 156: 3986-3992.
10. Kobayashi SD, Voyich JM, Braughton KR, Whitney AR, Nauseef WM, Malech HL, De-Leo FR: Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease. J Immunol 2004; 172: 636-643.
11. Borjesson DL, Kobayashi SD, Whitney AR, Voyich JM, Argue CM, DeLeo FR: Insights into pathogen immune evasion mechanisms: Anaplasma phagocytophilum fails to induce an apoptosis differentiation program in human neutrophils. J Immunol 2005; 174: 6364-6372.
12. DeLeo FR: Modulation of phagocyte apoptosis by bacterial pathogens. Apoptosis 2004; 9: 399-413.
13. McCaffrey RL, Allen L-AH: Pivotal advance: Francisella tularensis evades killing by human neutrophils via inhibition of the respiratory burst and phagosome escape. J Leukoc Biol 2006; 80: 1224-1230.
14. McCaffrey RL, Schwartz JT, Lindemann SR, Moreland JG, Buchan BW, Jones BD, Allen L-AH: Multiple mechanisms of NADPH oxidase inhibition by type A and type B Francisella tularensis . J Leukoc Biol 2010; 88: 791-805.
15. Schwartz JT, Barker JH, Kaufman J, Fayram DC, McCracken JM, Allen L-AH: Francisella tularensis inhibits the intrinsic and extrinsic pathways to delay constitutive apoptosis and prolong human neutrophil lifespan. J Immmunol 2012; 188: 3351-3363.
16. Proctor RA, White JD, Ayala E, Canonico PG: Phagocytosis of Francisella tularensis by rhesus monkey peripheral leukocytes. Infect Immun 1975; 11: 146-151.
17. Nauseef WW: Isolation of human neutrophils from venous blood. Methods Mol Biol 2007; 412: 15-20.
18. Koziel J, Maciag-Gudowska A, Mikolajczyk T, Bzowska M, Sturdevant DE, Whitney AR, Shaw LN, DeLeo FR, Potempa J: Phagocytosis of Staphylococcus aureus by macrophages exerts cytoprotective effects manifested by the upregulation of antiapoptotic factors. PLoS ONE 2009; 4: e5210.
19. Huang DW, Sherman BT, Lempicki RA: Systematic and integrative analysis of large gene lists using david bioinformatics resources. Nat Protoc 2008; 4: 44-57.
20. Huang DW, Sherman BT, Lempicki RA: Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009; 37: 1-13.
21. Gardai SJ, Whitlock BB, Xiao YQ, Bratton DB, Henson PM: Oxidants inhibit ERK/MAPK and prevent its ability to delay neutrophil apoptosis downstream of mitochondrial changes and at the level of XIAP. J Biol Chem 2004; 279: 44695-44703.
22. Brach M, deVos S, Gruss H, Herrmann F: Prolongation of survival of human polymorphonuclear neutrophils by granulocytemacrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 1992; 80: 2920-2924.
23. Hubert M, Engelen S: Robust PCA and classification in biosciences. Bioinformatics 2004; 20: 1728-1736.
24. Alter O, Brown PO, Botstein D: Singular value decomposition for genome-wide expression data processing and modeling. Proc Natl Acad Sci USA 2000; 97: 10101-10106.
25. Kobayashi SD, Voyich JM, Whitney AR, De-Leo FR: Spontaneous neutrophil apoptosis and regulation of cell survival by granulocyte macrophage-colony stimulating factor. J Leukoc Biol 2005; 78: 1408-1418.
26. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A: Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992; 80: 2012-2020.
27. Dunican AL, Leuenroth SJ, Ayala A, Simms HH: CXC chemokine suppression of polymorphonuclear leukocyte apoptosis and preservation of function is oxidative stress independent. Shock 2000; 13: 244-250.
28. Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD, Marshall JC: Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004; 113: 1318-1327.
29. Witko-Sarsat V, Pederzoli-Ribeil M, Hirsh E, Sozzani S, Cassatella MA: Regulating neutrophil apoptosis: new players enter the game. Trends Immunol 2011; 32: 117-124.
30. Altznauer F, Conus S, Cavalli A, Folkers G, Simon H-U: Calpain-1 regulates BAX and subsequent SMAC-dependent caspase-3 activation in neutrophil apoptosis. J Biol Chem 2004; 279: 5947-5957.
31. Gyrd-Hansen M, Meier P: IAPS: from caspase inhibitors to modulators of NF-B, inflammation and cancer. Nat Rev Cancer 2010; 10: 561-574.
32. van Raam BJ, Drewniak A, Groenewold V, van den Berg TK, Kuijpers TW: Granulocyte colony-stimulating factor delays neutrophil apoptosis by inhibition of calpains upstream of caspase-3. Blood 2008; 112: 2046-2054.
33. Yan B, Zemskova M, Holder S, Chin V, Kraft A, Koskinen PJ, Lilly M: The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death. J Biol Chem 2003; 278: 45358-45367.
34. Knepper-Nicolai B, Savill J, Brown SB: Constitutive apoptosis in human neutrophils requires synergy between calpains and the proteasome downstream of caspases. J Biol Chem 1998; 273: 30530-30536.
35. Ozaki Y, Kato T, Kitagawa M, Fujita H, Kitagawa S: Calpain inhibition delays neutrophil apoptosis via cyclic AMP-independent activation of protein kinase A and protein kinase A-mediated stabilization of Mcl- and X-linked inhibitor of apoptosis (XIAP). Arch Biochem Biophys 2008; 477: 227-231.
36. Ward C, Chilvers ER, Lawson MF, Pryde JG, Fujihara S, Farrow SN, Haslett C, Rossi AG: NF- B activation is a critical regulator of human granulocyte apoptosis in vitro. J Biol Chem 1999; 274: 4309-4318.
37. Hoffman B, Liebermann DA: Gadd45 modulation of intrinsic and extrinsic stress responses in myeloid cells. J Cell Physiol 2009; 218: 26-31.
38. Tamassia N, Zimmermann M, Cassatella MA: An additional piece in the puzzle of neutrophil-derived IL-1: the NLRP3 inflammasome. Eur J Immunol 2012; 42: 565-568.
39. Shiohara M, Taniguchi SI, Masumoto J, Yasui K, Koike K, Komiyama A, Sagara J: ASC, which is composed of a PYD and a CARD, is up-regulated by inflammation and apoptosis in human neutrophils. Biochem Biophys Res Commun 2002; 293: 1314-1318.
40. Blomgran R, Patcha Brodin V, Verma D, Bergström I, Söderkvist P, Sjöwall C, Eriksson P, Lerm M, Stendahl O, Särndahl E: Common genetic variations in the NALP3 inflammasome are associated with delayed apoptosis of human neutrophils. PLoS ONE 2012; 7: e31326.
41. Atianand MK, Duffy EB, Shah A, Kar S, Malik M, Harton JA: Francisella tularensis reveals a disparity between human and mouse NLRP3 inflammasome activation. J Biol Chem 2011; 286: 39033-39042.
42. Ulland TK, Buchan BW, Ketterer MR, Fernandes-Alnemri T, Meyerholz DK, Apicella MA, Alnemri ES, Jones BD, Nauseef WM, Sutterwala FS: Cutting edge: mutation of Francisella tularensis mviN leads to increased macrophage absent in melanoma 2 inflammasome activation and a loss of virulence. J Immmunol 2010; 185: 2670-2674.